Abstract: The present invention relates to a prefabricated infilled panel-frame structure capable of accommodating seismic-loading and seismic energy dissipation, and a construction method thereof, including a frame body, a prefabricated infilled panel group, a panel connector, and a disc spring assembly. During an earthquake, the present invention slides to dissipate energy only after the maximum starting sliding force is exceeded, thus providing the structure with a relatively high lateral stiffness prior to sliding. After an earthquake, the disc spring assembly of the present invention may provide a certain restoring force due to being compressed so as to reduce the residual displacement. Further, the present invention achieves the bidirectional deformation cooperation of the prefabricated infilled panel under earthquakes, so that the infilled panel may still achieve the function of seismic energy dissipation under the coupling action of in-plane and out-of-plane loads.

Abstract: A swallowable, foldable and self-expandable oral drug delivery tubular device, the device: comprising an outer peripheral surface; having an expanded length of about 2 cm to about 6 cm; having an expanded diameter of about 0.45 cm to about 6 cm; and comprising at least one cavity enclosing a drug, the at least one cavity facing outward from the outer peripheral surface of the device.

Abstract: The present disclosure provides a mucosal suction patch comprising at least one bulb containing a drug; the at least one bulb having an elasticity such that, upon applying mechanical pressure on a pressure applying surface of the patch, the at least one bulb is deformed, and when the mechanical pressure is released while the patch sealing surface is on a subject mucosa, the at least one bulb at least partially regains its expanded state, which in turn deforms the mucosa, which reversibly fills up at least part of the at least one bulb cavity, causing the drug to migrate in the mucosa. It also provides uses of the patch for the transmucosal delivery of a drug in a subject. This patch enables a non-invasive, non-parenteral systemic administration of drugs, particularly macromolecular drugs.

Abstract: Provided is a device for spraying an ammoniacal gas in an automatically-adjustable manner based on a flow rate

Abstract: The present invention relates to a prefabricated infilled panel-frame structure capable of accommodating seismic-loading and seismic energy dissipation, and a construction method thereof, including a frame body, a prefabricated infilled panel group, a panel connector, and a disc spring assembly. During an earthquake, the present invention slides to dissipate energy only after the maximum starting sliding force is exceeded, thus providing the structure with a relatively high lateral stiffness prior to sliding. After an earthquake, the disc spring assembly of the present invention may provide a certain restoring force due to being compressed so as to reduce the residual displacement. Further, the present invention achieves the bidirectional deformation cooperation of the prefabricated infilled panel under earthquakes, so that the infilled panel may still achieve the function of seismic energy dissipation under the coupling action of in-plane and out-of-plane loads.

Abstract: A series of deuterated nucleoside compounds are compounds represented by formula (IV), and stereoisomers or pharmaceutically acceptable salts thereof.

Abstract: Disclosed are a process route of a compound of a compound of formula (IV), a crystal form and a preparation method therefor. Also disclosed is an application of the crystal form in preparation of drugs for treating diseases associated with SSAO.

Abstract: Disclosed are a series of deuterated nucleoside compounds and a use thereof. Specifically disclosed are compounds represented by formula (VI-2), and stereoisomers or pharmaceutically acceptable salts thereof.

Abstract: Disclosed are a series of deuterated nucleoside compounds and a use thereof. Specifically disclosed are compounds represented by formula (VI-1), stereoisomers or pharmaceutically acceptable salts thereof.

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: Provided is an aldehyde binder, specifically, disclosed is a compound as represented by formula (II) or a pharmaceutically acceptable salt.

Abstract: A crystal form of a pyridinylphenyl compound and a preparation method therefor. Use of the crystal form in the preparation of a medicament of treating related diseases is also comprised.

Abstract: Provided is a call response method in the field of terminal technology. The call response method includes receiving a first call indication message and a second call indication message sent by a network device, determining a target state of the terminal device, and responding to the first call indication message or the second call indication message according to the target state to perform the PS call or the CS call.

Abstract: A crystal form (such as formula I) of a 2-methyl-2-propanol and amino-substituted aryl compound and a preparation method therefor. Also provided is an application of the crystal form in the preparation of a medicine for treating related diseases.

Abstract: A vaporizer is disclosed. The vaporizer includes a liquid storage housing having a liquid storage cavity formed therein and a base arranged at one end of the liquid storage housing. The base includes an air inlet protruding stage that has an upper surface facing the liquid storage cavity. The upper surface is in a shape of a protrusion. The air inlet protruding stage is provided with a plurality of air inlet holes extending from the upper surface away from the liquid storage cavity.

Abstract: An aminopyridine compound that may be used as an aldehyde trapping agent, and specifically disclosed is a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.

Abstract: A crystal form (such as formula I) of a 2-methyl-2-propanol and amino-substituted aryl compound and a preparation method therefor. Also provided is an application of the crystal form in the preparation of a medicine for treating related diseases.

Abstract: The present invention relates to a compound represented by formula (I), a tautomer thereof or a pharmaceutically acceptable salt thereof, and relates to applications thereof in the preparation of drugs for treating FXR related diseases.

Abstract: The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof.

Abstract: Disclosed are a composition comprising a compound as shown in formula (I) and a preparation method therefor, and the use of same in the preparation of a drug for treating ophthalmic diseases.